ArticlePDF Available

Abstract and Figures

In 1996, the prohibition of the cultivation of non-drug Cannabis sativa L. (hemp) with minor content of the psychoactive Δ-tetrahydrocannabinol (THC) was lifted in Germany. Nowadays, a wide variety of hemp food products is offered on the market. As help for evaluation of such products, this article provides information on all aspects of hemp as foodstuff. An introduction to the current law situation in Germany and the European Union (EU) is presented. In particular, suggestions for the food regulatory and food chemical evaluation of hemp food products are made. Between 1998 and 2003, a significant linear decrease in the THC concentrations for the product groups hemp tea (N = 19, R = −0.73, p < 0.0001) and hemp oil (N = 60, R = −0.23, p = 0.05) was observed. The prescribed use of certified hemp seed by the EU and the increase of controls on manufacturers have obviously led to a significant decline of THC concentrations in hemp food products. The maximum THC content in current purchasable hemp food products is ten to a hundred-fold lower than those found in the studies of the 1990s. These levels of THC in hemp food do not cause regulatory or health concern anymore. However, ongoing quality control is needed to maintain low THC levels. This includes both the use of low THC varieties and proper seed cleaning.
Content may be subject to copyright.
PEER-REVIEWED PAPERS
Current Status of THC
in German Hemp Food Products
Dirk W. Lachenmeier
Stephan G. Walch
ABSTRACT. In 1996, the prohibition of the cultivation of non-drug
Cannabis sativa L. (hemp) with minor content of the psychoactive
9-tetrahydrocannabinol (THC) was lifted in Germany. Nowadays, a
wide variety of hemp food products is offered on the market. As help for
evaluation of such products, this article provides information on all as-
pects of hemp as foodstuff. An introduction to the current law situation
in Germany and the European Union is presented. In particular, sugges-
tions for the food regulatory and food chemical evaluation of hemp food
products are made.
Between 1998 and 2003, a significant linear decrease in the THC con-
centrations for the product groups hemp tea (N = 19, R = 0.73, p <
0.0001) and hemp oil (N = 60, R = 0.23, p = 0.05) was observed. The
prescribed use of certified hemp seed by the EU and the increase of con-
trols on manufacturers have obviously led to a significant decline of
THC concentrations in hemp food products. The maximum THC con-
Dirk W. Lachenmeier and Stephan G. Walch are affiliated with Chemisches und
Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weißenburger Str. 3, D-76187 Karlsruhe,
Germany (Web-site: www.cvua-karlsruhe.de) (E-mail: Lachenmeier@web.de).
Journal of Industrial Hemp, Vol. 10(2) 2005
Available online at http://www.haworthpress.com/web/JIH
©2005 by The Haworth Press, Inc. All rights reserved.
doi:10.1300/J237v10n02_02 5
This electronic prepublication version may contain typographical errors and may be miss-
ing artwork such as charts, photographs, etc. Pagination in later versions may differ from
this copy; citation references to this material may be incorrect when this prepublication
edition is replaced at a later date with the finalized version.
tent in current purchasable hemp food products is ten to a hundred-fold
lower than those found in the studies of the 1990’s. These levels of THC
in hemp food do not cause regulatory or health concern anymore. How-
ever, ongoing quality control is needed to maintain low THC levels. This
includes both the use of low THC varieties and proper seed cleaning.
[Article copies available for a fee from The Haworth Document Delivery Ser-
vice: 1-800-HAWORTH. E-mail address: <docdelivery@haworthpress.com>
Website: <http://www.HaworthPress.com> ©2005 by The Haworth Press, Inc.
All rights reserved.]
KEYWORDS. Hemp food, hemp, Cannabis sativa L., cannabinoids,
tetrahydrocannabinol (THC), food regulation
INTRODUCTION
In 1996, after a long-time of prohibition in Germany, the law for nar-
cotics (BtMÄndV, 1996) was changed and since then the cultivation of
non-drug Cannabis (hemp) has been legal. As a consequence, hemp
containing food products are experiencing a revival. Since the mid
1990s, hemp food has gradually expanded into the natural product mar-
ket and it is increasingly found in natural food stores for its positive nu-
tritional and health benefits. The first hemp food product to reach the
market was hemp oil in 1995 (Karus, 1995). Nowadays various hemp
food products are available, for example hemp leaves (tea), hemp seeds,
hemp oil, flour, beverages (beer, lemonade), and cosmetic products. In
the meantime a flourishing trade is establishing itself via the internet.
In this article the development since 1996 concerning the psychoac-
tive cannabinoid 9-tetrahydrocannabinol (THC) in hemp food prod-
ucts is described, and guidelines to assist food control are given.
HEMP AS FOOD
The hemp plant is primarily a fiber supplier. As by-product the fruits,
small round nuts (usually called hemp seeds), are harvested and are sold
traditionally as bird or fish feed. Because of their fat content of 30-35%
they can also be used for the extraction of oil. It produces a green, me-
dium strong drying oil whose glycerides consist of 40-60% linolic acid
and 14-28% linolenic acid (Franke, 1997). The protein of the hemp seed
contains all 8 essential amino acids and they are in the necessary propor-
6 JOURNAL OF INDUSTRIAL HEMP
tions for human nutrition (Johnson, 1999; Mölleken, 1999). Hemp oil
contains the highest proportion of unsaturated fatty acids of all vegetable
oils, and contains nutritionally valuable essential fatty acids (approx.
75%) (Leizer et al., 2000; Mölleken, 1999). Therefore, the most promis-
ing product of Cannabis cultivation is the seed and its derived products
for utilization as food (Johnson, 1999).
A problem is that the unsaturated fatty acid molecules are susceptible
to oxidation, especially when they are exposed to light or heat (Mediavilla
et al., 1997). Therefore, hemp oil has a short shelf life in comparison to
other cold-pressed oils, such as olive oil. This disadvantage makes the
commercial exploitation of hemp oil difficult (Johnson, 1999; Matthäus
et al., 2001). In addition, hemp oils are avoided by many consumers be-
cause of the unfamiliar taste and smell (Mediavilla et al., 1997).
The application of hemp as food is currently restricted, because avail-
able hemp species have been bred to target a high fiber production and
not a high seed yield (de Meijer, 1995). The oil content of the fruits var-
ies between 9 and 34%. The most important breeding goal is, therefore,
to obtain ripe seeds under Central European conditions (El-Ghany,
2002). There is still some breeding potential, especially in regard to an
increase of the gamma-linolenic acid content, as well to increase the
tocopherol content for anti-oxidation protection of the oil (Matthäus et
al., 2001).
THC PROBLEM
Generally all parts of the Cannabis plant can contain cannabinoids.
The low but detectable concentration in the seeds, which do not contain
glandular trichomes, may be explained by diffusion of THC from other
parts of the plant before harvest. Higher concentrations may result from
further contamination during harvest. Therefore the cleanliness of the
seeds plays the most decisive part in the concentration of THC in the
seeds. The largest proportion of THC can be found on the surface of the
seed coat. As a consequence only very low THC concentrations are
found inside the seed (less than 2 mg/kg with drug Cannabis and less
than 0.5 mg/kg with non-drug Cannabis) (Ross et al., 2000).
For its application as a food product it is important that the THC con-
tent of the seeds is not increased by impurities from THC-rich plant
parts, nor by corresponding cultivation conditions (BgVV, 1997).
Because of the drug problem, the breeding of plants with low THC-
content was started in France and in the former Soviet-Union in the
Dirk W. Lachenmeier and Stephan G. Walch 7
1970s, followed by Hungary at the beginning of the 1980s (El-Ghany,
2002). Present day non-drug Cannabis species follow the guidelines of
the European Union (EU), which demand a THC-content of less than
0.2%. The selection of phenotypes with fewer than 0.05% THC has
been successful (El-Ghany, 2002; Mechtler et al., 2004). Psychoactive
effects from the consumption of non-drug Cannabis plant parts have not
been observable (Grotenhermen and Karus, 1998).
FOOD LEGISLATION
The THC limit for hemp (measured in the upper third of the plant) has
been gradually lowered from 0.5% (1984) to 0.2% (since 2002) (Coun-
cil of the European Communities, 1998). In Switzerland all plant variet-
ies of Cannabis can be grown legally, and some with high THC content
are usual. However THC content limitations were applied for hemp as
food (Mediavilla et al., 1997). After decontrol of hemp cultivation in
1996 (BtMÄndV, 1996) in Germany, the former federal institute for
health protection of consumers and veterinary medicine (BgVV, today:
Federal institute for risk assessment, BfR) estimated that the acceptable
daily intake should only be 1-2 µg/kg/day (BgVV, 1997). From these
estimations the following THC limits for food were derived in the year
2000: beverages (alcoholic and non-alcoholic): 5 µg/kg; edible oil:
5000 µg/kg; and other food: 150 µg/kg (BgVV, 2000).
Hemp cultivation for fiber production is subsidized in the European
Union and the THC content is controlled annually. Therefore, it is guar-
antied that only seed from varieties with a low THC content, according
to the maximum limit are used. It has turned out through the new, inten-
sified regulations, that the risk of cultivation of high-content THC spe-
cies is reduced to a minimum (Council of the European Union, 2000).
FOOD CHEMICAL ASPECTS
THC-Content of Hemp Food Products
Hemp food products, even those made from non-drug Cannabis,
commonly contain analyzable THC amounts (Table 1). Earlier analyses
of hemp oil revealed a wide range of concentrations, between 11.5-117.5
mg/kg (Bosy and Cole, 2000) and 7-150 mg/kg (Alt, 1997). The highest
concentrations found in oil were reported by a Swiss working group.
8 JOURNAL OF INDUSTRIAL HEMP
They obviously included products made from drug hemp in their analy-
ses: 4.1-880 mg/kg (Zoller et al., 2000), 3-1500 mg/kg (Lehmann et al.,
1997), and even 2-3568 mg/kg (Mediavilla et al., 1997). In hemp tea,
THC contents of 1020-1480 mg/kg (Zoller et al., 2000) and 5000 mg/kg
(Giroud et al., 1997) were discovered in the leaves, and between 1.0
mg/kg (Zoller et al., 2000) and 2.4 mg/kg (Giroud et al., 1997) in the re-
spective tea infusions. Low THC concentrations were only found in
beverages, such as beer (0.004-0.016 mg/l (Iten and Coray, 1996)) and
liqueur (0.02 mg/l (Alt and Reinhardt, 1997)), as well as in seed (0-12
mg/kg (Ross et al., 2000), 3.9-5.2 mg/kg (Zoller et al., 2000)). Apart
from the studies of the years 1996-2000, no current data about the THC
Dirk W. Lachenmeier and Stephan G. Walch 9
TABLE 1. THC content of selected hemp food products. Results from various
studies and own analyses (nd: not detected).
Hemp product Studies 1997-2000 (THC mg/kg) Studies 2004-2005 (THC mg/kg)
Oil 7-150 (Alt, 1997)
3-1500 (Lehmann et al., 1997)
2-3568 (Mediavilla et al., 1997)
4.1-880 (Zoller et al., 2000)
11.5-117.5 (Bosy and Cole, 2000)
1.36-12.4 (Lachenmeier et al., 2004)
2-3.3 (CVUA Karlsruhe)
0.025 (Pellegrini et al., 2005)
Tea (Leaves) 1020-1480 (Zoller et al., 2000)
5000 (Giroud et al., 1997)
4.37-15.53 (Lachenmeier et al.,
2004)
3.3-92.7 (CVUA Karlsruhe)
Tea (Infusion) 1.0 (Zoller et al., 2000)
2.4 (Giroud et al., 1997)
0.04-0.23 (Lachenmeier et al., 2004)
0.006-0.039 (CVUA Karlsruhe)
Beer 0.004-0.016 (Iten and Coray, 1996) nd (Lachenmeier et al., 2004)
nd (CVUA Karlsruhe)
0.005 (Pellegrini et al., 2005)
Liqueur 0.02 (Alt and Reinhardt, 1997) nd (CVUA Karlsruhe)
0.008 (Pellegrini et al., 2005)
Seeds 0-12 (Ross et al., 2000)
3.9-5.2 (Zoller et al., 2000)
0.29-3.36 (Lachenmeier et al., 2004)
0.28-2.6 (CVUA Karlsruhe)
0.328 (Pellegrini et al., 2005)
content of hemp food products are available. The CVUA Karlsruhe,
part of the German official food control system, analyzed the THC con-
tent of 19 hemp food products in 2004. In 15 products (79%) THC was
detected, while in the remaining 4 samples no THC was found. In com-
parison to earlier studies, the THC contents determined in recent years
were considerably lower. The reduced limit required for THC in seeds
seems to have the desired effect on hemp food products.
The results of the CVUA Karlsruhe are confirmed by a recent publi-
cation in which 30 hemp food products were examined (Lachenmeier et
al., 2004). Infringement of the THC limit was described only in isolated
cases. The THC content of hemp tea ranged from 4.37 to 15.53 mg/kg in
the Cannabis leaves and from 0.04 to 0.23 mg/kg in the tea infusion, ex-
ceeding the upper limit of the German guidance value for beverages.
High contents of THC, beyond the guidance value of 0.15 mg/kg for
other foods, were determined in seeds and flour (0.29-1.07 mg/kg), cold
cuts (0.20 mg/kg) and Cannabis pastilles (0.16 mg/kg). One oil sample
with 11.48 mg/kg also exceeded the guidance value for edible oils of 5
mg/kg. However, the majority of the analyzed samples revealed that
THC concentrations were below the guidance values; in the range
0.01-4.44 mg/kg. In two beverage samples (a soft drink and beer) THC
could not be detected, whereas in all samples cannabidiol (CBD) and
cannabinol (CBN) were present.
Our results were verified by another recent publication. Pellegrini et.
al (2005) analyzed six hemp food products from the Italian market find-
ing relatively low THC contents.
The prescribed use of certificated hemp seed by the EU and the in-
crease of controls on manufacturers have obviously led to a significant
decline of THC concentrations in hemp food products. In the USA it has
also been reported that, through a more careful cleaning of the seed,
since 1998, a significant decline in THC concentrations was achieved
(Leson et al., 2001). The maximum THC content in current purchasable
hemp food products (Lachenmeier et al., 2004) is ten to a hundred-fold
lower than those found in the studies of the 1990’s (Alt, 1997; Bosy and
Cole, 2000; Giroud et al., 1997; Lehmann et al., 1997; Mediavilla et al.,
1997; Zoller et al., 2000). In respect of the sample results of the CVUA
Karlsruhe between 1998 and 2003, and taking into account the values
described in the literature, a significant decrease in the THC concentra-
tions of hemp tea (N = 19, R = 0.73, p < 0.0001) and hemp oil (N = 60,
R=0.23, p = 0.05) was observed using linear regression. On the other
hand, in the case of seeds (N = 27, R = 0.29, p = 0.13) and beverages
10 JOURNAL OF INDUSTRIAL HEMP
(N = 34, R = 0.21, p = 0.22) no decrease in respect of the 5% level of
significance has been provable.
Origin of the Hemp Used for Food Product Manufacturing
Recently it was described that the simultaneous determination of
THC, CBD and CBN in hemp containing food products and a calcula-
tion of the Cannabis-phenotype-ratio ((THC + CBN)/CBD), allows dis-
crimination between non-drug and drug Cannabis as food ingredients
(Lachenmeier et al., 2004). In the majority of investigated samples, in-
cluding all products labeled as originating in the EU, CBD was the
analyte showing the highest concentration, and therefore the pheno-
type-ratio was below 1. In the evaluation of these products, it can be as-
sumed that they were derived from non-drug Cannabis in accordance to
the law. In Figure 1, the discrimination is visualized using principal
component analysis (PCA). The first component (PC1) divides the food
products into non-drug or drug Cannabis. Component 2 (PC2) depends
on the concentration of cannabinoids.
Only six of the examined products were derived from drug Cannabis.
It was noticed, that the origin of these products was partly Switzerland.
Due to the liberal legal situation, which allows the cultivation of all
Dirk W. Lachenmeier and Stephan G. Walch 11
Food derived from
non-drug
Cannabis
Food derived from
drug
Cannabis
PC2
PC1
10123456
3
2
1
0
1
FIGURE 1. Multivariate data analysis (PCA) for the visualization of 36 hemp
food products as given by Lachenmeier et al. (2004).
kinds of hemp, the use of drug-type Cannabis for food production can
be assumed. As a consequence, it is advisable that official food control
should determine the content of CBD and CBN simultaneously with the
THC content, because the phenotype-ratio can confirm the labeling of
origin of hemp food products. Of course, there are no health conse-
quences of hemp food derived from drug Cannabis if the THC content
is below the concentrations recommended by the BgVV. From the
viewpoint of consumer protection, no objection can then be made
against the import of such products of countries outside the EU that
have more liberal laws.
FOOD REGULATORY ASPECTS
The lowest oral administered dose of THC, which after repetitive ad-
ministration causes psychoactive effects in adults, is 2.5 mg/day. This is
equal to the administration of approximately 40 µg/kg of bodyweight per
day, if a bodyweight of 60 kg is assumed. Food products leading to the
uptake of such higher doses, if consumed daily, have to be considered a
threat to the consumer health and should therefore be controlled. To elim-
inate uncertainties, such as a variation in individual sensitivity, kinetic
specialties (redistribution, long half-life), interaction with other hemp or
food ingredients or certain drugs, the BgVV advises that a daily uptake of
1-2 µg/kg bodyweight should not be exceeded. This uptake limit is
20-40-fold lower than the lowest known effective dose (BgVV, 1997).
Marginal violations of the limit can usually be tolerated. Samples, which
exceed the limit twice, have to be considered to be deteriorated. Hemp
food products which greatly exceed the limit, and therefore contain
amounts of THC that are close to the lowest known effective dose have to
be judged as unfit for consumption. The CVUA Karlsruhe suggests that
the labeling of products as “THC free” should be considered as deceiving
the consumer, because a significant concentration of THC can be found
in every product. Products with low hemp content, but with a special
stress on the nutritional value of hemp, should be rated likewise.
RATING OF SPECIAL FOOD PRODUCTS
Hemp Beer
In work by Hupf et al. (1997) the organoleptical value, and therefore
the character of dried hemp inflorescence, watery infusions and beer ex-
12 JOURNAL OF INDUSTRIAL HEMP
tracts (called hemp beer) as food products were examined. After the
organoleptical tests, the authors came to the conclusion that none of the
products provided a significant consumption value. Official food con-
trol first classified hemp inflorescences as additives (BgVV, 1997) (e.g.
taste enhancing substance), but this opinion was not affirmed because it
was determined that they have prevailing attributes as food. Such prod-
ucts also do not fall into the requirements of regulation No 258/97 (EC)
regarding novel food products and ingredients (Taschan, 1999). Eul
(1997) pointed out that the ingredient “hemp” for beer distributed in
Germany does not comply with the German beer purity law. At present
only a few Swiss made products are available under the designation
“hemp beer”. The THC problem is of minor importance in this group of
products, because the lipophilic THC is extracted by the watery wort in
small amounts. In 1996, Swiss made hemp beer was analyzed by Iten
and Coray (1996) and only a marginal THC content between 3 and 16
µg/l was detected. In recent study (Lachenmeier et al., 2004), and in
experiments of the CVUA Karlsruhe, no THC could be detected in
hemp beer.
Hemp Seeds
A high concentration of THC in the seeds and the flour made from
them, can be caused either by an insufficient harvest technology that
leads to contamination of the seed with THC rich leaves (Ross et al.,
2000), or by inadequate cleaning and handling (Mediavilla et al., 1997).
The THC content of hemp oil is also caused by the concomitant extrac-
tion of leaves and resin, which stick to the seeds during oil production.
The THC content in oil products and seed has therefore to be under-
stood as a contamination that exists in many available products (Bosy
and Cole, 2000). Samples that exceed THC concentrations have to be
officially rejected because they are produced contrary to European law.
According to Council Regulation (EEC) No 315/93 laying down Com-
munity procedures for contaminants in food (Council of the European
Communities, 1993), no food containing a contaminant in an amount
unacceptable from the public health viewpoint, and in particular at a
toxicological level, should be placed on the market. Furthermore, con-
taminant levels should be kept as low as can be reasonably achieved
through following good practices. In our opinion, an offence against
good practices can be assumed if the BgVV limits are exceeded by more
than twice. Considering lot-to-lot differences and inhomogeneities in
the sampling process, manufacturers were advised of their duty to
Dirk W. Lachenmeier and Stephan G. Walch 13
exercise diligence and to use state-of-the-art measures needed to limit
the content of THC.
Hemp Tea
Hemp teas, the leaves of the hemp plant, have regularly shown to ex-
ceed THC limits. In contrast to the seed, the THC concentrations found
in hemp tea cannot be judged as contamination. In this case the cause is
the glandular trichomes of the leaves. A rejection of these products on
the basis of Council Regulation No 315/93 (Council of the European
Communities, 1993) is therefore impossible. A further problem is that it
is as yet uncertain whether the limits apply to the tea leaves or to the
infusion. An evaluation of the end product is the current practice. Tea
infusions are therefore made according to the instructions of the manu-
facturers, then analyzed and evaluated on the basis of 5 µg/kg as a limit.
If the limit is significantly exceeded, an objection against the product is
registered. The manufacturers are also informed of those cases where
tea products exceeded the limit, but not in such a way that they could be
declared as unfit for sale. Inhomogeneous tea samples lead to a big vari-
ation in analyzed THC concentrations. The manufacturers have been in-
formed of their obligation for diligence regarding their products, and
self-control measures were recommended if single batches exceeded
the limit. It should also be documented whether the THC content is a re-
sult of seasonal and annual fluctuations (e.g. different vegetation condi-
tions). Controls at the production level need to be put in place to test the
plants prior to production. It was further recommended that the conse-
quences for the recipe be documented, and that the amount of tea leaves
in each sale unit be controlled.
CONCLUSION
The critical product groups that should be intensively scrutinized by
official food control in the future are hemp seeds and their derived prod-
ucts (such as hemp flour, hemp oil). The seed, which is actually THC
free, is contaminated by THC rich leaves through inadequate harvest
technologies. In hemp oil an enrichment of the lipophilic cannabinoids
can be observed, especially if cleaning procedures are inadequate be-
fore oil production. If, in the case of seed products, an infringement of
the limit is detected, the manufacturer should be made aware of the
availability of state-of-the-art harvest and production technology, and
14 JOURNAL OF INDUSTRIAL HEMP
reminded of his obligation to take reasonable care with his products. In
fact, the product itself should not be the subject of rigorous testing but
the method of production. This may lead, if adopted as a strategy, to
hemp seed products being deregulated completely.
On the other hand, the case for hemp teas is more complex. Such
products require greater scrutiny because they are made of hemp leaves
which are rich in the glandular trichomes, in which the cannabinoids are
accumulated. Next to the covering leaves of the inflorescence they con-
tain the highest concentration of cannabinoids. The goal should be to
work towards Europe-wide regulations for hemp food products which
could replace national guidelines.
REFERENCES
Alt A., 1997. Lebensmittel auf Hanfbasis und deren forensische Bedeutung. In:
GTFCh-Symposium 1997, Verlag Dr. Helm, Heppenheim, Germany.
Alt A., Reinhardt G., 1997. Nahrungsmittel auf Hanfbasis und deren forensische
Bedeutung. Blutalkohol 34: 286-293.
BgVV, 1997. Einsatz von Hanf in Lebensmitteln kann gesundheitlich problematisch
sein. BgVV Pressedienst, Berlin, Germany.
BgVV, 2000. BgVV empfiehlt Richtwerte für THC (Tetrahydrocannabinol) in hanf-
haltigen Lebensmitteln. BgVV Pressedienst, Berlin, Germany.
Bosy T.Z., Cole K.A., 2000. Consumption and quantitation of D9-tetrahydrocanna-
binol in commercially available hemp seed oil products. Journal of Analytical Toxi-
cology 24: 562-566.
BtMÄndV, 1996. Siebte Verordnung zur Änderung betäubungsmittelrechtlicher Vor-
schriften. Bundesgesetzblatt I 562.
Council of the European Communities, 1993. Council Regulation (EEC) No 315/93
laying down Community procedures for contaminants in food. Official Journal of
the European Communities L37: 1-3.
Council of the European Communities, 1998. Council Regulation (EC) No 1420/98
amending Regulation (EEC) No 619/71 laying down general rules for granting aid
for flax and hemp. Official Journal of the European Communities L190: 7-8.
Council of the European Union, 2000. Proposal for a Council Regulation (EC) amend-
ing Regulation (EC) No 1251/1999 establishing a support system for producers of
certain arable crops to include flax and hemp grown for fiber. Official Journal of the
European Communities C56E: 17-18.
de Meijer E., 1995. Fiber hemp cultivars: a survey of origin, ancestry, availability and
brief agronomic characteristics. Journal of the International Hemp Association 2:
66-73.
El-Ghany M.E.A., 2002. Molekulargenetische Diversität einer monözischen und einer
diözischen Hanfsorte und Analyse des Fasergehaltes von verschiedenen Hanfformen.
Dissertation Martin-Luther-Universität, Halle-Wittenberg, Germany.
Dirk W. Lachenmeier and Stephan G. Walch 15
Eul H.K., 1997. Vom Pils über das Bilsenkraut- und Liebesbier bis zum Rein-
heitsgebot. Brauwelt 137: 2323-2325.
Franke W., 1997. Nutzpflanzenkunde: nutzbare Gewächse der gemäßigten Breiten,
Subtropen und Tropen. Georg Thieme Verlag, Stuttgart, Germany.
Giroud C., Augsburger M., Rivier L., Mangin P., 1997. Hemp tea versus hemp milk:
subjective effects and elimination studies of THC and its main metabolite. In Pro-
ceedings XXXV TIAFT Meeting, Padova, Italy.
Grotenhermen F., Karus M., 1998. Industrial hemp is not marijuana: comments on the
drug potential of fiber Cannabis. Journal of the International Hemp Association 5:
96-101.
Hupf H., Gerstenberg H., Zeitler K., 1997. “Nutzhanf-Drinks”. Zur Frage nach der
Lebensmitteleigenschaft (Genußwert) und der rechtlichen Zuordnung von Nutzhanf.
Brauwelt 137: 2119-2123.
Iten P.X., Coray M., 1996. Hanf-Bier neu auf dem Markt in der Schweiz-THC-Gehalt
und forensische Bedeutung. In: 75. Jahrestagung der Deutschen Gesellschaft für
Rechtsmedizin, Zurich, Switzerland.
Johnson P., 1999. Industrial hemp: a critical review of claimed potentials for Cannabis
sativa. TAPPI Journal 82: 113-123.
Karus M., 1995. Hanf-Ökorohstoff mit Zukunft? In Biorohstoff Hanf-Tagungsband
zum Symposium, Nova Institut, Cologne, Germany.
Lachenmeier D.W., Kroener L., Musshoff F., Madea B., 2004. Determination of
cannabinoids in hemp food products by use of headspace solid-phase micro-extrac-
tion and gas chromatography-mass spectrometry. Analytical and Bio-analytical
Chemistry 378: 183-189.
Lehmann T., Sager F., Brenneisen R., 1997. Excretion of cannabinoids in urine after
ingestion of cannabis seed oil. Journal of Analytical Toxicology 21: 373-375.
Leizer C., Ribnicky D., Poulev A., Dushenkov S., Raskin I., 2000. The composition of
hemp seed oil and its potential as an important source of nutrition. Journal of
Nutraceuticals, Functional & Medical Foods 2: 35-53.
Leson G., Pless P., Grotenhermen F., Kalant H., Elsohly M.A., 2001. Evaluating the
impact of hemp food consumption on workplace drug tests. Journal of Analytical
Toxicology 25: 691-698.
Matthäus B., Brühl L., Kriese U., Schumann E., Peil A., 2001. Hanföl: ein “Highlight”
für die Küche. Forschungsreport 2/2001: 22-25.
Mechtler K., Bailer J., de Hueber K., 2004. Variations of D9-THC content in single
plants of hemp varieties. Industrial Crops and Products 19: 19-24.
Mediavilla V., Derungs R., Känzig A., Mägert A., 1997. Qualität von Hanfsamenöl aus
der Schweiz. Agrarforschung 4: 449-451.
Mölleken H., 1999. Hanf (Cannabis sativa) als Novel Food. Bioforum 7-8: 452-457.
Pellegrini M., Marchei E., Pacifici R., Pichini S., 2005. A rapid and simple procedure
for the determination of cannabinoids in hemp food products by gas chromatogra-
phy-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 36:
939-946.
Ross S.A., Mehmedic Z., Murphy T.P., Elsohly M.A., 2000. GC-MS analysis of the to-
tal D9-THC content of both drug- and fiber-type cannabis seeds. Journal of Analyti-
cal Toxicology 24: 715-717.
16 JOURNAL OF INDUSTRIAL HEMP
Taschan H., 1999. Hanfhaltige Lebensmittel: Psychedelische Lebensmittel, neuartige
Lebensmittel oder Rauschmittel? Verbraucherdienst 44: 144-148.
Zoller O., Rhyn P., Zimmerli B., 2000. High-performance liquid chromatographic
determination of D9-tetrahydrocannabinol and the corresponding acid in hemp con-
taining foods with special regard to the fluorescence properties of D9-tetrahydro-
cannabinol. Journal of Chromatography A 872: 101-110.
RECEIVED: 17 November 2004
ACCEPTED IN REVISED FORM: 25 March 2005
Dirk W. Lachenmeier and Stephan G. Walch 17
... The only exploitable byproduct that has been legally accepted is as an additive (i.e. taste enhancing substance) for beers or teas (Lachenmeier and Walch, 2006). Up until few years ago, its high CBD content was not considered by the market as valuable. ...
... Contrary to Italy, France has never completely stopped the cultivation of hemp. It was the first country -along with the Soviet Union -where breeding of hemp plants started in the 1970s (Lachenmeier and Walch, 2006) and French farmers cultivate the largest number of hectares in Europe. The cultivation of hemp is allowed only to use its fibers and seeds and is authorized on the basis of a contract with an authorized transformer through a Common Agricultural Policy file. ...
Thesis
Full-text available
Over the past decades, the cannabis policy paradigm has been changing with most Western countries allowing its medical use and few jurisdictions where any adults can legally purchase it. The basic question is no longer whether countries should legalize cannabis, but which policy should be adopted in order to maximize social welfare. While a basic legal guidance emerged from the experience of other addictive substances, cannabis regulation is a more complex policy challenge, given its product heterogeneity and the differential harms caused by its consumption across different types of users. When over-consumed, it can inflict harm to the users and others, whereas when is used as a medicine, it can improve the quality of life. In the midst of these extreme purposes, there is the spectrum of wellness and the industrial uses of potential economic and environmental interest. The thesis explores a major distinctive feature which characterizes the legal framework of cannabis distribution : the existence of multiple interrelated markets operating with different regulations, but that can often satisfy consumer demand interchangeably. Based on the expected purpose of use, analogous cannabis-based products arc supplied in different distributional channels characterized by substantially different transaction costs for consumers. It is the first attempt to systematically examine cannabis markets comprehensively and to consider how supply architecture and taxation (or subsidies) of one market can affect the others creating market distortions. Its contribution will extend to the institutionalization of other commodities with intoxicating potential, such as other forms of herbal medicine.
... This has initiated a large number of studies regarding the use of hemp as a functional food. Today, various hempbased food products are available on the market, such as hemp leaves (tea), seeds, flour, oil, beverages (Lachenmeier & Walch, 2006;Schultz et al., 2020;Zuk-Golaszewska & Golaszewski, 2018). ...
... This is because hemp seeds do not possess any cannabinoid-secreting glandular hair. The THC found in the analysis of hemp seed products is often the result of contamination of the seeds during harvest through contact with flowers [7], which can explain the exceptionally high value in some outlier samples. ...
Article
Full-text available
9-Tetrahydrocannabinol (THC) is known as the main psychotropic compound present in the hemp plant. It also occurs in commercially available hemp food products and may have adverse effects on consumers. This article provides an overview of the current situation of the THC content in hemp food products in Germany in recent years. The content of THC was evaluated in a data set of 5 different hemp food product groups (tea, seeds, seed oils, food supplements, and nonalcoholic beverages) comprising 511 samples. For the toxicological assessment, the THC intake was estimated and the exhaustion of acute reference dose (ARfD) and lowest observed adverse effect level (LOAEL) was calculated using average daily consumption scenarios. Data show that hemp beverages and seeds typically do not contain amounts of THC that can exceed toxicological thresholds. On the contrary, hemp food supplements, such as cannabidiol (CBD) products, can contain high levels of THC, since the THC content of 18% of the samples has the potential to exceed the LOAEL and 8% even exceed the minimum intoxication dose. However, a significant linear decrease in the THC content of hemp food supplements was observed between 2018 and 2021 (n = 111, R = -0.36, p < 0.0001). A problematic food group is also tea based on flowers, leading to an increase in overall THC levels in recent years. Regulation of low-THC products within the framework of controlled distribution of cannabis for recreational use appears to be advisable.
... However, processed products, which contain hemp leaves are often regarded as safe and therefore legal, if the Δ 9 -THC content does not exceed certain levels and an abuse as a narcotic drug can be ruled out. As explicitly excluded by the definition of cannabis in the UN single convention [4], seed products (e.g., hemp seed oil), without the cannabinoid-rich resin, are generally regarded as safe and may be marketed in the EU [5,6]. Besides Δ 9 -THC, the non-psychotropic cannabidiol (CBD, Figure 1c) gained increasing popularity due to a broad spectrum of health-promoting effects ascribed to it with several reviews on safety and efficacy available [7][8][9][10][11][12][13][14][15][16][17][18]. ...
Article
Full-text available
Cannabidiol (CBD) is a naturally occurring, non-psychotropic cannabinoid of the hemp plant Cannabis sativa L. and has been known to induce several physiological and pharmacological effects. While CBD is approved as a medicinal product subject to prescription, it is also widely sold over the counter (OTC) in the form of food supplements, cosmetics and electronic cigarette liquids. However, regulatory difficulties arise from its origin being a narcotic plant or its status as an unapproved novel food ingredient. Regarding the consumer safety of these OTC products, the question whether or not CBD might be degraded into psychotropic cannabinoids, most prominently tetrahydrocannabinol (THC), under in vivo conditions initiated an ongoing scientific debate. This feature review aims to summarize the current knowledge of CBD degradation processes, specifically the results of in vitro and in vivo studies. Additionally, the literature on psychotropic effects of cannabinoids was carefully studied with a focus on the degradants and metabolites of CBD, but data were found to be sparse. While the literature is contradictory, most studies suggest that CBD is not converted to psychotropic THC under in vivo conditions. Nevertheless, it is certain that CBD degrades to psychotropic products in acidic environments. Hence, the storage stability of commercial formulations requires more attention in the future.
Article
Full-text available
Cannabidiol (CBD)-containing products are widely marketed as over the counter products. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to acid-catalysed cyclization of CBD to psychotropic Δ ⁹ -tetrahydrocannabinol (Δ ⁹ -THC) in the stomach after oral consumption. However, research of pure CBD solutions stored in simulated gastric juice or subjected to various storage conditions such as heat and light with specific liquid chromatographic/tandem mass spectrometric (LC/MS/MS) and ultra-high pressure liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC-QTOF) analyses was unable to confirm THC formation. Another hypothesis for the adverse effects of CBD products may be residual Δ ⁹ -THC concentrations in the products as contamination, because most of them are based on hemp extracts containing the full spectrum of cannabinoids besides CBD. Analyses of 413 hemp-based products of the German market (mostly CBD oils) confirmed this hypothesis: 48 products (12%) contained Δ ⁹ -THC above the lowest observed adverse effect level (2.5 mg/day). Hence, it may be assumed that the adverse effects of some commercial CBD products are based on a low-dose effect of Δ ⁹ -THC, with the safety of CBD itself currently being unclear with significant uncertainties regarding possible liver and reproductive toxicity. The safety, efficacy and purity of commercial CBD products is highly questionable, and all of the products in our sample collection showed various non-conformities to European food law such as unsafe Δ ⁹ -THC levels, hemp extracts or CBD isolates as non-approved novel food ingredients, non-approved health claims, and deficits in mandatory food labelling requirements. In view of the growing market for such lifestyle products, the effectiveness of the instrument of food business operators' own responsibility for product safety and regulatory compliance must obviously be challenged, and a strong regulatory framework for hemp products needs to be devised.
Article
Full-text available
Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to acid-catalysed cyclization of CBD to psychotropic Δ ⁹ tetrahydrocannabinol (Δ ⁹ THC) in the stomach after oral consumption. However, research of pure CBD solutions stored in simulated gastric juice or subjected to various storage conditions such as heat and light with specific liquid chromatographic/tandem mass spectrometric (LC/MS/MS) and ultra-high pressure liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC-QTOF) analyses was unable to confirm THC formation. Another hypothesis for the adverse effects of CBD products may be residual Δ ⁹ THC concentrations in the products as contamination, because most of them are based on hemp extracts containing the full spectrum of cannabinoids besides CBD. Analyses of 362 hemp-based products of the German market (mostly CBD oils) confirmed this hypothesis: 39 products (11%) contained Δ ⁹ THC above the lowest observed adverse effect level (2.5 mg/day). Hence, it may be assumed that the adverse effects of some commercial CBD products are based on a low-dose effect of Δ ⁹ THC, with the safety of CBD itself currently being unclear with significant uncertainties regarding possible liver and reproductive toxicity. The safety, efficacy and purity of commercial CBD products is highly questionable, and all of the products in our sample collection showed various non-conformities to European food law such as unsafe Δ ⁹ THC levels, hemp extracts or CBD isolates as non-approved novel food ingredients, non-approved health claims, and deficits in mandatory food labelling requirements. In view of the growing market for such lifestyle products, the effectiveness of the instrument of food business operators' own responsibility for product safety and regulatory compliance must obviously be challenged, and a strong regulatory framework for hemp products needs to be devised.
Article
Full-text available
Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to hydrolytic conversion of CBD to psychotropic Δ ⁹ -tetrahydrocannabinol (Δ ⁹ -THC) in the stomach after oral consumption. However, research of pure CBD solutions stored in simulated gastric juice or subjected to various storage conditions such as heat and light with specific liquid chromatographic/tandem mass spectrometric (LC/MS/MS) and ultra-high pressure liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC-QTOF) analyses was unable to confirm THC formation. Another hypothesis for the adverse effects of CBD products may be residual Δ ⁹ -THC concentrations in the products as contamination, because most of them are based on hemp extracts containing the full spectrum of cannabinoids besides CBD. Analyses of 293 food products of the German market (mostly CBD oils) confirmed this hypothesis: 28 products (10%) contained Δ ⁹ -THC above the lowest observed adverse effect level (2.5 mg/day). Hence, it may be assumed that the adverse effects of some commercial CBD products are based on a low-dose effect of Δ ⁹ -THC, with the safety of CBD itself currently being unclear with significant uncertainties regarding possible liver and reproductive toxicity. The safety, efficacy and purity of commercial CBD products is highly questionable, and all of the products in our sample collection showed various non-conformities to European food law such as unsafe Δ ⁹ -THC levels, hemp extracts or CBD isolates as non-approved novel food ingredients, non-approved health claims, and deficits in mandatory food labelling requirements. In view of the growing market for such lifestyle products, the effectiveness of the instrument of food business operators' own responsibility for product safety and regulatory compliance must obviously be challenged, and a strong regulatory framework for hemp products needs to be devised.
Article
Full-text available
The objective of the study was to investigate the effects of using increasing levels of hemp seed oil (HSO) instead of soybean oil (SO) in broiler diets during the first 21 d of the starting period on growth, meat and serum parameters and the fatty acid profile of abdominal fat. A total of 200 one-day-old broiler chicks (Ross 308) were allocated to 4 dietary groups having different levels of HSO as 5 replicates. Dietary groups included the control (basal diet and 100% SO), HOG1 (basal diet and 25% HSO+75% SO), HOG2 (basal diet and 50% HSO+50% SO), and HOG3 (basal diet and 100% HSO). Results showed that each level of HSO in the diet significantly suppressed growth when compared to the control group (P<0.05) with the worst performance observed in HOG3 (P<0.05). Dietary HSO did not affect meat quality and serum parameters. However, HSO prevented meat oxidation and thiobarbituric acid reactive substances (TBARS) concentration in the 1st d of storage was significantly low in all the HSO groups and in the 7th d of storage only in the HOG3 group (P<0.05). The abdominal fat profile was modulated by dietary HSO, with the highest α-linolenic acid (ALA) was detected in the HOG3 group (P<0.05). ƩMUFA (total monounsaturated fatty acid) and ƩPUFA (total polyunsaturated fatty acid) contents of abdominal fat changed depending on the level of HSO in the diet. Consequently, despite the advantageous effects of HSO on abdominal fatty acids and meat oxidation its levels added to the diet in the current study were not suitable for broiler chickens at an early age. KEYWORDS: malondialdehyde concentration / meat colour/ fatty acid profile/ soy oil *This research was funded by the Selcuk University; scientific research projects (BAP) with the project number 20401075 in 2020.
Article
Full-text available
Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements. Adverse effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to hydrolytic conversion of CBD to psychotropic Δ ⁹ -tetrahydrocannabinol (Δ ⁹ -THC) in the stomach after oral consumption. However, research of pure CBD solutions stored in simulated gastric juice or subjected to various storage conditions such as heat and light with specific liquid chromatographic/tandem mass spectrometric (LC/MS/MS) and ultra-high pressure liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC-QTOF) analyses was unable to confirm THC formation. Another hypothesis for the adverse effects of CBD products may be residual Δ ⁹ -THC concentrations in the products as contamination, because most of them are based on hemp extracts containing the full spectrum of cannabinoids besides CBD. Analyses of 181 food products of the German market (mostly CBD oils) confirmed this hypothesis: 21 products (12%) contained Δ ⁹ -THC above the lowest observed adverse effect level (2.5 mg/day). Inversely, CBD was present in the products below the no observed adverse effect level. Hence, it may be assumed that the adverse effects of some commercial CBD products are based on a low-dose effect of Δ ⁹ -THC and not due to effects of CBD itself. The safety, efficacy and purity of commercial CBD products is highly questionable, and all of the products in our sample collection showed various non-conformities to European food law such as unsafe Δ ⁹ -THC levels, hemp extracts or CBD isolates as non-approved novel food ingredients, non-approved health claims, and deficits in mandatory food labelling requirements. In view of the growing market for such lifestyle products, the effectiveness of the instrument of food business operators' own responsibility for product safety and regulatory compliance must obviously be challenged, and a strong regulatory framework for hemp products needs to be devised.
Article
Full-text available
Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements, to avoid the strict rules of medicinal products. Side-effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to hydrolytic conversion of CBD to psychotropic Δ9-tetrahydrocannabinol (Δ9-THC) in the stomach after oral consumption. However, research of pure CBD solutions stored in simulated gastric juice or subjected to various storage conditions such as heat and light with specific liquid chromatographic/tandem mass spectrometric (LC/MS/MS) and ultra-high pressure liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC-QTOF) analyses was unable to confirm THC formation. Another hypothesis for the side-effects of CBD products may be residual Δ9-THC concentrations in the products as contamination, because most of them are based on crude hemp extracts containing the full spectrum of cannabinoids besides CBD. Analyses of 67 food products of the German market (mostly CBD oils) confirmed this hypothesis: 17 products (25%) contained Δ9-THC above the lowest observed adverse effects level (2.5 mg/day). Inversely, CBD was present in the products below the no observed adverse effect level. Hence, it may be assumed that the adverse effects of some commercial CBD products are based on a low-dose effect of Δ9-THC and not due to effects of CBD itself. The safety, efficacy and purity of commercial CBD products is highly questionable, and all of the products in our sample collection showed various non-conformities to European food law such as unsafe Δ9-THC levels, full-spectrum hemp extracts as non-approved novel food ingredients, non-approved health claims, and deficits in mandatory food labelling requirements. In view of the growing market for such lifestyle products, the effectiveness of the instrument of food business operators' own responsibility for product safety must obviously be challenged.
Article
Full-text available
The fatty acid and natural product content of hemp seed oil was analyzed by GC-MS and LC-MS. The presence of linoleic acid (LA) and -linolenic acid (LNA) were confirmed in their previously reported ratio of 3:1 LA:LNA. The presence of -caryophyllene (740 mg/L), myrcene (160 mg/L), -sitosterol (100-148 g/L) and trace amounts of methyl salicylate was observed in the oil which had not been previously reported. Trace amounts of cannabidiol (CBD) were also detected. Bioassays were performed with the oil to determine its effectiveness as an antimicrobial agent. Some bioactivity was observed during the primary screening. (Article copies available for a fee from The Haworth Document Delivery Service: 1-800-342-9678. E-mail address: Website: )
Article
Full-text available
Gas chromatographic-mass spectrometric (GC-MS) quantitation of 25 cannabis sed oils determined delta 9-tetrahydrocannabinol (THC) concentrations from 3 to 1500 micrograms/g oil. In a pilot study, the morning urine of six volunteers who had ingested 11 or 22 g of the oil, which contained the highest THC content (1500 micrograms/g), was collected for six days. The urine samples were screened by immunoassay, and the content of 11-nor-9-carboxy-delta 9-THC (THCCOOH) was determined by GC-MS. Urine samples were found cannabis positive for up to six days with THCCOOH-equivalent concentrations up to 243 ng/mL. by the Abuscreen OnLine immunoassay and THCCOOH contents from 5 to 431 ng/mL by the GC-MS method. All subjects reported THC-specific psychotropic effects.
Article
In recent years, hemp (Cannabis sativa) has received a great deal of attention in the United States and abroad, Around the world, C. sativa has been and is being used for numerous industrial and commercial applications, including pulp and paper, building materials, textiles, cosmetics, food products, and nutritional supplements. However, there has been tremendous "hype" surrounding the environmental benefits of using C. sativa vs. traditional raw materials. This paper aims to dispel the hype by investigating several claims that have been made regarding the potentials of industrial hemp: its cultivation requirements, its use as a biomass fuel,its use as seeds and oil for human nutrition,and particularly its use as a wood alternative. A review of some of the current and traditional pulping techniques for Cannabis sativa is provided.
Article
Within a given plant population, the concentration of any constituent is expected to vary within a certain bandwidth. To test the distribution of Δ9-tetrahydrocannabinol (THC) in hemp populations, a number of single plants were taken from populations of five well-known hemp accessions (Fasamo, Beniko, Bialobrzeskie, Félina 34, Kompolti) and a Hungarian provenance. The quantitative analysis of single plants delivered a set of 30–61 THC and Cannabidiol (CBD) values for each of the six hemp accessions under consideration. The distribution of THC within a number of hemp plants often shows no Gaussian distribution, the different varieties have quite characteristic distributions of THC. Most single-plant values are close together, the variation, however, differing from variety to variety. In addition, single plants are found with THC values far outside this bandwidth.
Article
After previous examination of oils containing hemp a series of other foodstuff containing hemp was analysed. All products were freely available on the market. In all products Tetrahydrocannabinol (THC) could be detected. In some it was accompanied by Cannabinol and Cannabidiol. The THC content in urine were at such a level that, assuming normal consumption, they could not be detected in urine tests in all but one case. Particularly the examined hemp lequeur showed no effect whatsoever in terms of psychotropic influence. It did however have an intoxication influence due to the alcohol content.
Article
A solvent programmed reversed-phase HPLC method with UV detection for the determination of delta9-tetrahydrocannabinol (THC) and delta9-tetrahydrocannabinolic acid A (THCA-A) in foods containing parts of hemp such as edible oil, herb-teas (infusion), herbal hemp or hempseed is presented. The THC peak is also detected by fluorescence. The detection limits with UV detection are 0.01 ng for THC and 0.05 ng for THCA-A and with fluorescence detection 0.1 ng for THC. The relative standard deviation under repeatability conditions of the chromatographic procedure is about 0.5% and that of the over-all analytical procedure for THC in vegetable oils 2% (concentration range of 10-100 mg/kg).
Article
There has been a recent and significant increase in the use and availability of hemp seed oil products. These products are being marketed as a healthy source of essential omega fatty acids when taken orally. Although the health aspects of these oils is open to debate, the probability that oils derived from the hemp seed will contain delta9-tetrahyrdocannabinol (THC) is noteworthy. Recent additions to the literature cite a number of studies illustrating that the ingestion of these products results in urinary levels of the THC metabolite, delta9-tetrahyrdocannabinol carboxylic acid (THCA), well above the administrative cutoff (50 ng/mL) used during random drug screens. Testing performed by our laboratory found that the concentration of THC in hemp oil products has been reduced considerably since the publication of earlier studies. The purpose of this study is to quantitate the THC levels in commercially available hemp oils and to administer those oils tested to THC-free volunteers to determine urine metabolite levels following several 15-g doses. Two extraction protocols were evaluated for removing THC from the oil matrix: a single step liquid-liquid extraction was compared to a two-phase process using both liquid-liquid and solid-phase techniques. Gas chromatography-mass spectrometry was used to determine THC levels in several products: four from Spectrum Essentials (3 bottled oils and 1-g capsules), two from Health from the Sun (1-g capsules and bottled oil) oils, and single samples of both Hempstead and Hempola hemp oils. These hemp oil products contained THC concentrations of 36.0, 36.4, 117.5, 79.5, 48.6, 45.7, 21.0, and 11.5 mg/g, respectively. The Abbott AxSYM FPIA and Roche On-Line KIMS immunoassays were used to screen the urine samples, and GC-MS was used to determine the amount of THC in each oil as well as confirm and quantitate THCA in the urine of study participants immediately before and 6 h after each dose. Peak THCA levels in the participants' urine ranged from 1 to 49 ng/mL. All volunteers were below positive screen and confirmation cutoffs within 48 h after cessation of ingestion.